Daniel Gonzalez works to improve medication dosing in children.
After Myron Cohen watched the first patient at UNC Hospitals die from AIDS in 1982, he knew it was a disease to be reckoned with. He spent the next 40 years helping to recruit the most promising infectious disease experts from across the nation to build a program that’s become a leader in HIV. Today, UNC excels in understanding all aspects of HIV, from prevention to a potential cure — expertise that is now being used to tackle COVID-19.
Aaron Anselmo is an assistant professor in the UNC Eshelman School of Pharmacy. He develops new strategies and technologies that alter the microbiome by removing pathogens and increasing beneficial bacteria.
A new technique uses stem cells to deliver anti-cancer drugs to aggressive brain tumors that are, otherwise, often inaccessible. This potentially life-saving treatment was developed by UNC pharmacoengineer Shawn Hingtgen.
Two UNC researchers design a biological test to individualize chemotherapy.